. Author manuscript; available in PMC: 2013 Aug 27.

Published in final edited form as: Mol Genet Metab. 2011 Oct 7;105(1):34–43. doi: 10.1016/j.ymgme.2011.09.032

Table 4.

Blood and CSF lactate and pyruvate concentrations in patients with PDC deficiency.

	Blood Lactate (mmol/L)	Blood Pyruvate (mmol/L)	Blood L:P Ratio	CSF Lactate (mmol/L)	CSF Pyruvate (mmol/L)
Total	7.8 ± 5.6 (216)	0.76 ± 2.3 (118)	19.6 ± 22 (45)	6.1 ± 3.04 (123)	0.47 ± 0.27 (43)
E1	9.9 ± 8.2 (16)	0.67 ± 0.99 (15)	18.6 ± 7.2 (5)	5.90 ± 4.5 (9)	0.57 ± 0.4 (4)
E1a	7.02 ± 5.8 (115)	0.56 ± 0.83 (66)	20.1 ± 25.6 (32)	6.07 ± 3 (74)	0.48 ± 0.27 (26)
E1b	11.8 ± 6.6 (8)		20.2 ± 0.28 (2)
E2	2.58 ± 2.1 (3)	0.137 (1)		1.4 ± 0.39 (2)
E3	11.3 ± 4.6 (15)	4.37 ± 8.6 (7)		3.01 ± 1.47 (4)
E3BP	10.3 ± 6.9 (21)	0.56 ± 0.43 (10)	13.4 ± 4.7 (5)	6.03 ± 2.3 (6)	0.53 ± 0.06 (2)
Unclassified	6.0 ± 2.6 (38)	0.37 ± 0.19 (19)	17.6 (1)	6.9 ± 2.8 (28)	0.40 ± 0.26 (11)